Linagliptin price in Pakistan (2026)

There is no fixed public retail price for linagliptin in Pakistan in the sources we track (most supply is hospital- or named-patient based). Use the Bangladesh list price as the benchmark: BDT 6–BDT 25 (US$0.05–US$0.20) per unit, about PKR 13.53–PKR 56.35 in PKR per unit and PKR 405.75–PKR 1,691 per 30-unit month, before freight, customs duty and distributor margin.

Yes, but only through the rules of the Drug Regulatory Authority of Pakistan (DRAP): Pakistan has a large domestic generic industry and DRAP-capped MRPs, which keeps locally produced generics cheap; oncology molecules are frequently sourced from Bangladesh or India instead of local production. Imported medicines need a DRAP import licence and a named-patient justification for unregistered products. Prescription medicines must move on a valid prescription through a licensed importer, pharmacy or hospital; personal-use imports need a named-patient / compassionate-use authorisation.

We cannot confirm the registration status of every individual generic brand in Pakistan. Drug Regulatory Authority of Pakistan (DRAP) is the approving authority, and only products with a local product registration (or a special import authorisation) may be sold routinely. Ask your supplier for the local registration or import permit for the specific brand before you buy.

Bangladesh is a least-developed-country WTO member with a pharmaceutical patent exemption running to 2033, so local manufacturers can legally produce molecules that are still on patent elsewhere — and DGDA-registered list prices are public. That makes it the practical global floor price for on-patent targeted therapy and the benchmark used in import negotiations.